AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
MOUNTAIN VIEW, Calif., June 25, 2024 /PRNewswire/ -- AliveCor, the global leader in AI-powered cardiology, today announced the U.S. Food & Drug Administration (FDA) clearance and commercial launch of ...
AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...
Please provide your email address to receive an email when new articles are posted on . AliveCor announced the FDA clearance and launch of its AI for ECG interpretation and streamlined, handheld ECG ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, announced today that ...
Twelve-lead ECGs, although standard in hospitals, can be bulky and impractical for home use. On the other hand, Apple Watch’s ECG app is easy to use, but it is limited in what it can detect because it ...
AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback